Simplex Trading
NVNO

Simplex Trading’s enVVeno Medical NVNO Stock Holding History

Simplex Trading’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,659
Closed -$29.9K – 9826
2025
Q4 		$29.9K Buy
2,659
+2,266
+577% +$44K ﹤0.01% 6117
2025
Q3 		$12K Buy
+393
New +$40.1K ﹤0.01% 7761
2024
Q4 		– Sell
-8
Closed -$894 – 9288
2024
Q3 		$0 Sell
8
-11
-58% -$2.02K ﹤0.01% 9233
2024
Q2 		$3K Buy
+19
New +$3.32K ﹤0.01% 8139
2023
Q4 		– Sell
-507
Closed -$80.7K – 9497
2023
Q3 		$95K Buy
+507
New +$84.6K ﹤0.01% 5140

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's NVNO Position: Q1 2026 in Review

Simplex Trading sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 2,659 shares — an estimated $29.9K sold.

Simplex Trading first reported a position in NVNO in Q3 2023 and held it in 5 quarters. The position peaked at $95K in Q3 2023. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Simplex Trading reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 2,659 enVVeno Medical shares in Q1 2026, an estimated $29.9K.
  • Simplex Trading first reported a position in enVVeno Medical in Q3 2023 and held it in 5 quarters.
  • Simplex Trading's enVVeno Medical position peaked at $95K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.